{{Rsnum
|rsid=2076169
|Gene=PPARD
|Chromosome=6
|position=35420702
|Orientation=minus
|GMAF=0.1051
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=PPARD
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 0.0 | 21.4 | 78.6
| HCB | 5.9 | 30.4 | 63.7
| JPT | 2.7 | 31.9 | 65.5
| YRI | 0.0 | 0.0 | 100.0
| ASW | 0.0 | 5.3 | 94.7
| CHB | 5.9 | 30.4 | 63.7
| CHD | 10.1 | 45.9 | 44.0
| GIH | 2.0 | 27.7 | 70.3
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 8.6 | 91.4
| MKK | 0.0 | 0.0 | 0.0
| TSI | 2.0 | 17.6 | 80.4
| HapMapRevision=28
}}{{PMID Auto
|PMID=21245421
|Title=Genetic Factors Underlying the Risk of Thalidomide-Related Neuropathy in Patients With Multiple Myeloma
}}

{{PMID|17855759|OA=1
}} Regulation of skeletal muscle PPAR delta mRNA expression in twins.

{{PMID|18657264|OA=1
}} Interaction between Calpain 5, Peroxisome proliferator-activated receptor-gamma and Peroxisome proliferator-activated receptor-delta genes: a polygenic approach to obesity.

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}